Business
Recce (ASX:RCE) share price edges lower following study delays
Image source: Getty Images
The Recce Pharmaceuticals Ltd (ASX: RCE) share price is falling after the company released an update on its clinical pipeline. In afternoon trade, shares in Recce Pharmaceuticals are trading 0.46% lower at $1.08.
The update announced delays to the…
Continue Reading
-
General10 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General14 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News18 hours agoWave of cruises headed for Sunshine Coast this summer
-
General22 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’